Trusted Pharmacy Blog|New Drugs, Drug News, Health, Medications, Diseases

The FDA has approved updated labeling for cetuximab (Erbitux, ImClone/ Bristol-Myers Squibb) to include overall survival data. Cetuximab is indicated for the treatment of EGFR-expressing, meta-static colorectal carcinoma after unsuccessful regimens of both irinotecan (Camptosar, Pfizer) and oxaliplatin (Eloxatin, Sanofi-Synthelabo). As a single agent, cetuximab is also indicated for the treatment of EGFR-expressing metastatic colorectal cancer in patients intolerant to irinotecan-based regimens.

Read the rest of this entry »

Metformin (Glucophage drugs , Bristol-Myers Squibb) may help protect against cancer. Researchers from the University of Dundee in the United Kingdom found a 37% reduced risk with metformin and say that their findings warrant a randomized trial. During 10 years of follow-up, cancer occurred in 297 of 4,085 patients (7.3%) new to using metformin, compared with 474 (11.6%) of 4,085 non-users.

Read the rest of this entry »